Nontuberculous mycobacteria and the lung: from suspicion to treatment
- PMID: 20379826
- DOI: 10.1007/s00408-010-9240-9
Nontuberculous mycobacteria and the lung: from suspicion to treatment
Abstract
Nontuberculous mycobacteria (NTM) are resilient bacteria that grow in virtually any environment, especially those where competing microorganisms are destroyed, such as in chlorinated water. They have been discovered in soil, dust, food, water, and domestic and wild animals. Nontuberculous mycobacteria tend to infect individuals with local (e.g., damaged skin or lung) or systemic (e.g., HIV, drugs, malignancy) defects in host defence, and their incidence and prevalence have consistently increased in the last decade. Difficulty may arise in determining whether an isolated NTM from a microbiological sample is in fact a contaminant or a pathogenic organism. In this review, we discuss the important mycobacteria involved in lung disease, factors that predispose individuals to infection, and their diagnosis and treatment according to updated guidelines. English language publications in MEDLINE and references from relevant articles from January 1, 1990 to June 28, 2009 were reviewed. Keywords searched were "nontuberculous,""mycobacteria," "diagnosis," and "treatment."
Similar articles
-
Diagnosis and treatment of patients with pulmonary nontuberculous mycobacterial diseases in Arkhangelsk, Russia.Infect Genet Evol. 2019 Sep;73:358-361. doi: 10.1016/j.meegid.2019.05.022. Epub 2019 Jun 1. Infect Genet Evol. 2019. PMID: 31163274
-
Management of nontuberculous mycobacterial (NTM) lung disease.Semin Respir Crit Care Med. 2013 Feb;34(1):135-42. doi: 10.1055/s-0033-1333575. Epub 2013 Mar 4. Semin Respir Crit Care Med. 2013. PMID: 23460013
-
Nontuberculous mycobacteria infections in immunosuppressed hosts.Clin Chest Med. 2015 Mar;36(1):91-9. doi: 10.1016/j.ccm.2014.11.002. Epub 2014 Dec 23. Clin Chest Med. 2015. PMID: 25676522 Free PMC article. Review.
-
Medications and monitoring in nontuberculous mycobacteria infections.Clin Chest Med. 2015 Mar;36(1):55-66. doi: 10.1016/j.ccm.2014.11.001. Epub 2014 Dec 18. Clin Chest Med. 2015. PMID: 25676519 Review.
-
Medical Management of Pulmonary Nontuberculous Mycobacterial Disease.Thorac Surg Clin. 2019 Feb;29(1):65-76. doi: 10.1016/j.thorsurg.2018.09.001. Thorac Surg Clin. 2019. PMID: 30454923 Review.
Cited by
-
Mycobacterial infections in patients treated with tumor necrosis factor antagonists in South Korea.Lung. 2013 Oct;191(5):565-71. doi: 10.1007/s00408-013-9481-5. Epub 2013 Jun 1. Lung. 2013. PMID: 23728990
-
Disseminated Mycobacterium abscessus infection with idiopathic CD4+ T-lymphocytopenia: a case report and review of the literature.J Med Case Rep. 2024 Dec 31;18(1):645. doi: 10.1186/s13256-024-05009-w. J Med Case Rep. 2024. PMID: 39741340 Free PMC article. Review.
-
A role for c-Myc in regulating anti-mycobacterial responses.Proc Natl Acad Sci U S A. 2011 Oct 25;108(43):17749-54. doi: 10.1073/pnas.1104892108. Epub 2011 Oct 12. Proc Natl Acad Sci U S A. 2011. PMID: 21997212 Free PMC article.
-
Radiological features and therapeutic responses of pulmonary nontuberculous mycobacterial disease in rheumatoid arthritis patients receiving biological agents: a retrospective multicenter study in Japan.Mod Rheumatol. 2012 Sep;22(5):727-37. doi: 10.1007/s10165-011-0577-6. Epub 2011 Dec 30. Mod Rheumatol. 2012. PMID: 22207481 Free PMC article.
-
Historical evolution of the diseases caused by non-pigmented rapidly growing mycobacteria in a University Hospital.Rev Esp Quimioter. 2019 Oct;32(5):451-457. Epub 2019 Sep 19. Rev Esp Quimioter. 2019. PMID: 31535542 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical